At. Myklebust et al., NUDE RAT MODELS FOR HUMAN TUMOR-METASTASIS TO CNS - PROCEDURES FOR INTRACAROTID DELIVERY OF CANCER-CELLS AND DRUGS, Journal of neuro-oncology, 21(3), 1994, pp. 215-224
Models for hematogenous spread of human cancer to the central nervous
system (CNS) were established by injecting human tumor cells into the
internal carotid artery of nude rats. With 4 out of 10 cell lines, bel
onging to four different tumor types, metastases developed in all inje
cted animals. Tumor growth manifested clinically as neurological sympt
oms which appeared after a median latency ranging from 19-87 days for
the different tumors. The H-146 and DMS-273 small cell lung cancers an
d the LOX melanoma almost exclusively gave meningeal tumors, whereas w
ith FEMX-I melanoma cells bone metastases in the skull dominated. For
these tumor types a correlation was found between the capacity for exp
erimental metastasis formation and the s.c. tumorigenicity. In agreeme
nt with clinical experience, none of the 2 sarcoma and 2 glioblastoma
lines gave CNS metastases. With a modified microsurgical technique, al
lowing for repeated ipsilateral intracarotid injections, we analyzed t
he drug concentrations obtained in tumor and surrounding brain tissue
after i.v. treatment with doxorubicin. The concentration in the LOX tu
mor reached therapeutic levels and was approximately 100 x higher than
in normal brain tissue, both with and without intraarterial pretreatm
ent with arabinose. In the same model, the tissue concentrations of 9.
2.27-abrin immunotoxin 10 min after intracarotid injection were examin
ed. Although the levels were low, a tumor to brain concentration ratio
of up to 9 was achieved. The data demonstrate that clinically relevan
t tumor models can be established with the techniques described, and t
hese models may successfully be used to evaluate the pharmacokinetics
and effect of intravenous or intraarterial therapy.